Eli Lilly

Loading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co. Looking at options history for Eli Lilly...

The market expects Eli Lilly (LLY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024....

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded he...

The most recent trading session ended with Eli Lilly (LLY) standing at $731.33, reflecting a +0.69% shift from the previouse trading day's closing. This change...

Loading... Loading... On Monday, Eli Lilly and Company LLY agreed to acquire a manufacturing facility from Nexus Pharmaceuticals. The deal terms were not discl...

Dive Brief: Eli Lilly on Monday said it will acquire a drug plant from Nexus Pharmaceuticals to expand its manufacturing capacity for injectable medicines. Lo...

For pharmaceutical company Eli Lilly (NYSE:LLY), it’s been doing some great things of late with a string of drugs. And, seeing that supply is getting to be an i...

April 22 (Reuters) - Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines. Lilly e...

Eli Lilly (NYSE:LLY) has agreed to acquire a manufacturing facility from Nexus Pharmaceuticals to further expand its global parenteral (injectable) product manu...

Loading... Loading... A recent survey conducted by Morgan Stanley reveals that the use of GLP-1 drugs, popular for weight loss and diabetes, is affecting consu...